BRPI0515344A - composto, composição farmacêutica, e, usos de uma quantidade eficaz de um composto 3-fosfoindol ou sal, pró-droga, estereoisÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo e de uma quantidade de tratamento eficaz anti-hiv de um composto de 3-fosfoindol ou sal, pró-droga, estereo-isÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo - Google Patents
composto, composição farmacêutica, e, usos de uma quantidade eficaz de um composto 3-fosfoindol ou sal, pró-droga, estereoisÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo e de uma quantidade de tratamento eficaz anti-hiv de um composto de 3-fosfoindol ou sal, pró-droga, estereo-isÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmoInfo
- Publication number
- BRPI0515344A BRPI0515344A BRPI0515344-1A BRPI0515344A BRPI0515344A BR PI0515344 A BRPI0515344 A BR PI0515344A BR PI0515344 A BRPI0515344 A BR PI0515344A BR PI0515344 A BRPI0515344 A BR PI0515344A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- tautomer
- stereoisomer
- prodrug
- oxide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61106104P | 2004-09-17 | 2004-09-17 | |
| US71144505P | 2005-08-25 | 2005-08-25 | |
| US71156505P | 2005-08-26 | 2005-08-26 | |
| PCT/IB2005/004063 WO2006054182A2 (en) | 2004-09-16 | 2005-09-16 | Phosphoindoles as hiv inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0515344A true BRPI0515344A (pt) | 2008-07-15 |
Family
ID=36407947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0515344-1A BRPI0515344A (pt) | 2004-09-17 | 2005-09-16 | composto, composição farmacêutica, e, usos de uma quantidade eficaz de um composto 3-fosfoindol ou sal, pró-droga, estereoisÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo e de uma quantidade de tratamento eficaz anti-hiv de um composto de 3-fosfoindol ou sal, pró-droga, estereo-isÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7534809B2 (https=) |
| EP (3) | EP2256124A1 (https=) |
| JP (1) | JP5031569B2 (https=) |
| KR (1) | KR101242962B1 (https=) |
| CN (1) | CN102304150B (https=) |
| AT (2) | ATE479693T1 (https=) |
| AU (1) | AU2005305609B2 (https=) |
| BR (1) | BRPI0515344A (https=) |
| CA (1) | CA2583409C (https=) |
| CY (1) | CY1109440T1 (https=) |
| DE (2) | DE602005011031D1 (https=) |
| DK (1) | DK1799696T3 (https=) |
| ES (1) | ES2320252T3 (https=) |
| HR (1) | HRP20090086T3 (https=) |
| IL (1) | IL181909A0 (https=) |
| MX (1) | MX2007003040A (https=) |
| NO (1) | NO20071871L (https=) |
| NZ (1) | NZ554232A (https=) |
| PL (1) | PL1799696T3 (https=) |
| PT (1) | PT1799696E (https=) |
| RS (1) | RS50981B (https=) |
| SG (1) | SG155939A1 (https=) |
| SI (1) | SI1799696T1 (https=) |
| WO (1) | WO2006054182A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005011031D1 (en) | 2004-09-17 | 2008-12-24 | Idenix Pharmaceuticals Inc | Phosphoindole als hiv-inhibitoren |
| KR20090077813A (ko) | 2006-09-29 | 2009-07-15 | 아이데닉스 파마슈티칼스, 인코포레이티드 | Ｈｉｖ 억제제로서의 거울상이성질체적으로 순수한 포스포인돌 |
| US20100113421A1 (en) * | 2006-10-06 | 2010-05-06 | Williams Theresa M | Non-nucleoside reverse transcriptase inhibitors |
| BRPI0811645A2 (pt) | 2007-05-30 | 2014-11-11 | Hoffmann La Roche | Inibidores de transcriptase reversa de não-nucleosídeo |
| TW200946541A (en) * | 2008-03-27 | 2009-11-16 | Idenix Pharmaceuticals Inc | Solid forms of an anti-HIV phosphoindole compound |
| TW200944537A (en) * | 2008-04-03 | 2009-11-01 | Idenix Pharmaceuticals Inc | Formulations comprising a phosphoindole compound and one or more second active agents |
| EP2393822B1 (en) * | 2009-02-03 | 2014-07-16 | IDENIX Pharmaceuticals, Inc. | Phosphinate ruthenium complexes |
| EP2403860B1 (en) * | 2009-03-04 | 2015-11-04 | IDENIX Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole as hcv polymerase inhibitors |
| PE20121524A1 (es) | 2010-01-27 | 2012-12-03 | Viiv Healthcare Co | Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos |
| CN103275126B (zh) * | 2013-05-28 | 2016-03-23 | 兰州大学 | 一种立体选择性合成3-位膦酰化吲哚的方法 |
| ITMI20131218A1 (it) * | 2013-07-19 | 2015-01-20 | Need Pharma Srl | Nuovi ureido derivati di acidi naftalensolfonici |
| CA3079140A1 (en) * | 2017-10-13 | 2019-04-18 | Ursure, Inc. | Products and methods for monitoring adherence to nucleoside reverse transcriptase inhibitor therapy |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4866084A (en) | 1987-07-17 | 1989-09-12 | Harbor Branch Oceanographic Institution, Inc. | Topsentin compounds effective against viruses and certain tumors |
| US5124327A (en) * | 1991-09-06 | 1992-06-23 | Merck & Co., Inc. | HIV reverse transcriptase |
| US5527819A (en) * | 1991-09-06 | 1996-06-18 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
| DE4217964A1 (de) * | 1992-05-30 | 1993-12-02 | Goedecke Ag | Indolocarbazol-Imide und deren Verwendung |
| HUT74614A (en) | 1993-02-24 | 1997-01-28 | Merck & Co Inc | Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them |
| US5424329A (en) | 1993-08-18 | 1995-06-13 | Warner-Lambert Company | Indole-2-carboxamides as inhibitors of cell adhesion |
| US5612330A (en) | 1994-03-07 | 1997-03-18 | Warner-Lambert Company | Methods for inhibiting and controlling viral growth |
| US5489586A (en) * | 1994-03-07 | 1996-02-06 | Warner-Lambert Company | Method for treating inflammatory disease in humans |
| US5489685A (en) * | 1994-05-12 | 1996-02-06 | Merck & Co., Ltd. | Method of synthesizing furo[2,3-b]pyridine carboxylic acid esters |
| US5852011A (en) | 1994-05-31 | 1998-12-22 | Mitsui Chemicals, Inc. | Benzimidazole derivatives |
| US5734081A (en) * | 1994-08-05 | 1998-03-31 | Warner-Lambert Company | Arylthio compounds |
| US5981525A (en) * | 1995-01-10 | 1999-11-09 | Smithkline Beecham Corporation | Indole derivatives useful in the treatment of osteoporosis |
| US6011021A (en) | 1996-06-17 | 2000-01-04 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
| US6046180A (en) * | 1996-06-17 | 2000-04-04 | Guilford Pharmaceuticals Inc. | NAALADase inhibitors |
| US6017903A (en) * | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US6025345A (en) * | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
| US6025344A (en) | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Certain dioic acid derivatives useful as NAALADase inhibitors |
| GB9614347D0 (en) * | 1996-07-09 | 1996-09-04 | Smithkline Beecham Spa | Novel compounds |
| PL332413A1 (en) | 1996-09-27 | 1999-09-13 | Guilford Pharm Inc | Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals |
| US5830894A (en) * | 1997-02-21 | 1998-11-03 | Viropharma Incorporated | Methods for preventing and treating pestivirus infection and associated diseases |
| US5935982A (en) | 1997-02-28 | 1999-08-10 | The University Of North Carolina At Chapel Hill | Methods of treating retroviral infection and compounds useful therefor |
| US6068988A (en) | 1997-02-28 | 2000-05-30 | Biosynth Ag | Detection of microbial metabolites with a 3-indoxyl-myo-inositol-1-phosphate compound |
| EP0994707A4 (en) * | 1997-05-27 | 2001-11-14 | Guilford Pharm Inc | INHIBITORS OF NAALADASE ENZYME ACTIVITY |
| PL343249A1 (en) | 1998-03-26 | 2001-07-30 | Shionogi & Co | Indole derivatives with antiviral activity |
| IT1299068B1 (it) | 1998-04-10 | 2000-02-07 | Chemi Spa | Legandi fosforati chirali e loro complessi organometallici, utili come catalizzatori in sintesi stereoselettive |
| GB9914371D0 (en) | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| WO2002083126A1 (en) * | 2001-04-11 | 2002-10-24 | Idenix (Cayman) Limited | Phenylindoles for the treatment of hiv |
| US6825201B2 (en) | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| JP3368273B1 (ja) * | 2001-12-28 | 2003-01-20 | 株式会社トミー | 動作玩具の駆動装置及び動作玩具 |
| US20030236277A1 (en) * | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| AU2003231765B9 (en) * | 2002-04-26 | 2010-01-28 | Gilead Sciences, Inc. | Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| US6900206B2 (en) * | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| US20040063746A1 (en) * | 2002-07-25 | 2004-04-01 | Alicia Regueiro-Ren | Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| AU2003258145A1 (en) | 2002-08-07 | 2004-02-25 | Idenix (Cayman) Limited | Substituted phenylindoles for the treatment of hiv |
| DE602005011031D1 (en) | 2004-09-17 | 2008-12-24 | Idenix Pharmaceuticals Inc | Phosphoindole als hiv-inhibitoren |
| KR20090077813A (ko) | 2006-09-29 | 2009-07-15 | 아이데닉스 파마슈티칼스, 인코포레이티드 | Ｈｉｖ 억제제로서의 거울상이성질체적으로 순수한 포스포인돌 |
-
2005
- 2005-09-16 DE DE602005011031T patent/DE602005011031D1/de not_active Expired - Lifetime
- 2005-09-16 SG SG200906239-9A patent/SG155939A1/en unknown
- 2005-09-16 HR HR20090086T patent/HRP20090086T3/xx unknown
- 2005-09-16 EP EP10174740A patent/EP2256124A1/en not_active Withdrawn
- 2005-09-16 KR KR1020077008493A patent/KR101242962B1/ko not_active Expired - Fee Related
- 2005-09-16 CN CN201110185299.9A patent/CN102304150B/zh not_active Expired - Fee Related
- 2005-09-16 AT AT08075531T patent/ATE479693T1/de not_active IP Right Cessation
- 2005-09-16 PL PL05850774T patent/PL1799696T3/pl unknown
- 2005-09-16 JP JP2007531877A patent/JP5031569B2/ja not_active Expired - Fee Related
- 2005-09-16 PT PT05850774T patent/PT1799696E/pt unknown
- 2005-09-16 DK DK05850774T patent/DK1799696T3/da active
- 2005-09-16 WO PCT/IB2005/004063 patent/WO2006054182A2/en not_active Ceased
- 2005-09-16 DE DE602005023360T patent/DE602005023360D1/de not_active Expired - Lifetime
- 2005-09-16 AT AT05850774T patent/ATE414092T1/de active
- 2005-09-16 NZ NZ554232A patent/NZ554232A/en not_active IP Right Cessation
- 2005-09-16 ES ES05850774T patent/ES2320252T3/es not_active Expired - Lifetime
- 2005-09-16 EP EP08075531A patent/EP1961757B1/en not_active Expired - Lifetime
- 2005-09-16 RS RSP-2009/0057A patent/RS50981B/sr unknown
- 2005-09-16 MX MX2007003040A patent/MX2007003040A/es active IP Right Grant
- 2005-09-16 SI SI200530547T patent/SI1799696T1/sl unknown
- 2005-09-16 BR BRPI0515344-1A patent/BRPI0515344A/pt not_active IP Right Cessation
- 2005-09-16 CA CA2583409A patent/CA2583409C/en not_active Expired - Fee Related
- 2005-09-16 AU AU2005305609A patent/AU2005305609B2/en not_active Ceased
- 2005-09-16 US US11/229,150 patent/US7534809B2/en active Active
- 2005-09-16 EP EP05850774A patent/EP1799696B1/en not_active Expired - Lifetime
-
2007
- 2007-03-13 IL IL181909A patent/IL181909A0/en unknown
- 2007-04-12 NO NO20071871A patent/NO20071871L/no not_active Application Discontinuation
-
2008
- 2008-11-21 US US12/275,510 patent/US8044091B2/en not_active Expired - Lifetime
-
2009
- 2009-02-04 CY CY20091100127T patent/CY1109440T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4424372A3 (en) | Compounds and methods for treatment of viral infections | |
| WO2021262826A3 (en) | 1'-cyano nucleoside analogs and uses thereof | |
| CY1109440T1 (el) | Φωσφοϊνδολες ως αναστολεις hiv | |
| DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| PH12020551891A1 (en) | New quinoline derivatives | |
| BRPI0508540A8 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| UY30310A1 (es) | Derivados 2-azetidinona, sales, solvatos, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
| TW200502230A (en) | Dual nk1/nk3 derivatives | |
| DK2173749T3 (da) | 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl)-acetamidderivater og beslægtede forbindelser som antisvampemidler | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| MX390044B (es) | Derivados de naftiridinona y su uso en el tratamiento de la arritmia. | |
| AR056369A1 (es) | Compuestos derivados de quinazolina y composicion farmaceutica | |
| AR064543A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
| WO2007077203A3 (en) | Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases | |
| BRPI0808377B8 (pt) | composto, composição e uso de um composto | |
| MX2024003015A (es) | Nuevos derivados de quinolina. | |
| WO2004089943A8 (en) | Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues | |
| AR054888A1 (es) | Derivados de quinolina como agentes antibacterianos | |
| WO2007075650A3 (en) | Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders | |
| WO2004096147A3 (en) | Oxo-pyrimidine compounds | |
| BRPI0520097A2 (pt) | composto ou estereoisÈmeros únicos, misturas de estereoisÈmeros, ou sais farmaceuticamente aceitáveis dos mesmos, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo | |
| TW200602329A (en) | Novel diazine derivatives, their manufacture and use as pharmaceutical agents | |
| WO2006076598A3 (en) | Bicyclic heterocycles as cannabinoid receptor modulators | |
| WO2006076569A3 (en) | Bicyclic heterocycles as cannabinoid receptor modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |